Evidence map›Paper›PMID 24443569›Full record

ArticleThe Journal of biological chemistry2014

The different inhibition mechanisms of OXA-1 and OXA-24 β-lactamases are determined by the stability of active site carboxylated lysine.

Tao Che, Christopher R Bethel, Marianne Pusztai-Carey, Robert A Bonomo, Paul R Carey

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tao CheFrom the Departments of Biochemistry.
Christopher R Bethel
Marianne Pusztai-Carey
Robert A Bonomo
Paul R Carey
Cleveland Research (United States) · USLouis Stokes Cleveland VA Medical Center · US

Funding

Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
A Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4M
RAMAN STUDIES OF ENZYME COMPLEXES IN SOLUTION &CRYSTALSR01GM054072 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CAREY, PAUL R · 1996 to 2013
$3.5M
Raman Spectroscopic Analysis of Beta-Lactamase Drug InteractionsR56GM054072 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CAREY, PAUL R · 2009 to 2009
$359k
NIAID NIH HHS R01 AI063517NIAID NIH HHS R01-AI063517NIAID NIH HHS R01 AI100560NIAID NIH HHS R01-AI100560NIGMS NIH HHS GM54072NIGMS NIH HHS R01 GM054072NIGMS NIH HHS R56 GM054072
6 · The paper itself

Abstract

The catalytic efficiency of class D β-lactamases depends critically on an unusual carboxylated lysine as the general base residue for both the acylation and deacylation steps of the enzyme. Microbiological and biochemical studies on the class D β-lactamases OXA-1 and OXA-24 showed that the two enzymes behave differently when reacting with two 6-methylidene penems (penem 1 and penem 3): the penems are good inhibitors of OXA-1 but act more like substrates for OXA-24. UV difference and Raman spectroscopy revealed that the respective reaction mechanisms are different. The penems form an unusual intermediate, a 1,4-thiazepine derivative in OXA-1, and undergo deacylation followed by the decarboxylation of Lys-70, rendering OXA-1 inactive. This inactivation could not be reversed by the addition of 100 mM NaHCO3. In OXA-24, under mild conditions (enzyme:inhibitor = 1:4), only hydrolyzed products were detected, and the enzyme remained active. However, under harsh conditions (enzyme:inhibitor = 1:2000), OXA-24 was inhibited via decarboxylation of Lys-84; however, the enzyme could be reactivated by the addition of 100 mM NaHCO3. We conclude that OXA-24 not only decarboxylates with difficulty but also recarboxylates with ease; in contrast, OXA-1 decarboxylates easily but recarboxylates with difficulty. Structural analysis of the active site indicates that a crystallographic water molecule may play an important role in carboxylation in OXA-24 (an analogous water molecule is not found in OXA-1), supporting the suggestion that a water molecule in the active site of OXA-24 can lower the energy barrier for carboxylation significantly.

Indexed as

Acinetobacter baumanniiAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesCatalytic DomainCrystallography, X-RayEnzyme ActivationEnzyme InhibitorsEnzyme StabilityEscherichia coliEscherichia coli ProteinsLysineMeropenemThienamycinsAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-lactamase OXA-2beta-lactamase OXA-24beta-LactamasesEnzyme InhibitorsEscherichia coli ProteinsLysineMeropenemThienamycinsCarboxylated LysineCrystallographyEnzyme MechanismsOXA-1OXA-24PenemsPhysical MethodsRaman SpectroscopyUV Spectroscopy

Identifiers

PMID24443569
PMCPMC3937681
OpenAlexW1981168034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.